4
Changes in Ownership
GeneDx Holdings Corp. Filed Acc 0001689575-26-000007
CHIEF EXECUTIVE OFFICER sold 1,653 shares at $94.00 ($155,375)
- CHIEF EXECUTIVE OFFICER acquired 3,874 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Stueland Katherine CHIEF EXECUTIVE OFFICER | 2026-01-29 | Option exercise | +3,874 | 18,111 | D | ||
| Stueland Katherine CHIEF EXECUTIVE OFFICER | 2026-01-29 | Sale | −1,653 | $94.00 | $155,375 | 16,458 | D |
| Derivatives | |||||||
| Stueland Katherine CHIEF EXECUTIVE OFFICER | 2026-01-29 | Option exercise · Restricted Stock Unit | −3,874 | 3,874 | D | ||
| Open-market sales · 1,653 sh · avg $94.00 · $155,375 | |||||||
Loading xslF345X05/form4-02022026_090231.xml…